This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Cellectar Biosciences, Inc.. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2022
Title: Nathan Stehle: Innovator in Cancer Therapeutics
Introduction
Nathan Stehle is a prominent inventor based in Madison, WI (US), known for his significant contributions to cancer therapeutics. With a total of 4 patents, he has focused on developing innovative solutions aimed at targeting cancer cells and cancer stem cells.
Latest Patents
One of Nathan's latest patents is titled "Phospholipid ether analogs as cancer-targeting drug vehicles." This invention is directed to therapeutic compounds capable of specifically targeting cancer cells and cancer stem cells. The patent further details compositions comprising these therapeutic compounds and methods of treating cancer through their administration.
Career Highlights
Nathan Stehle is currently associated with Cellectar Biosciences, Inc., where he continues to advance his research in cancer treatment. His work is pivotal in the development of new therapeutic strategies that could potentially improve patient outcomes in oncology.
Collaborations
Nathan has collaborated with notable colleagues, including Jamey Paul Weichert and Anatoly Pinchuk, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Nathan Stehle's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents and ongoing research hold promise for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile